What are the stages of chronic kidney disease? Here's what you need to know about the symptoms and slowing progression.

导读慢性肾脏病（CKD）的患病率较高，但知晓率较低，与其临床症状不明显，许多患者在确诊时就已经是CKD晚期或终末期肾脏病。检查和诊断较为复杂相关。只有早发现、早诊断、早治疗才可能有效管理CKD。因此，如何快速、简单的检查、诊断CKD以及对CKD进行风 ...

美国肾脏病学会年会（ASN）肾脏周是国际规模最大、学术水平最高的肾脏病学术盛会。今年 10 月 24～27 日（美国时间），第 57 届 ASN Kidney Week 2024 ...

SAN DIEGO -- Finerenone (Kerendia) yielded minimal renal benefit in patients with heart failure with mildly reduced or ...

SAN DIEGO -- Antibiotic prophylaxis may help to protect kidneys of kids with vesicoureteral reflux during febrile urinary ...

Doctors use your creatinine levels to estimate how well your kidneys are filtering the blood, which is called the glomerular filtration rate (GFR). Normal creatinine levels Creatinine levels vary ...

An analysis of the FINEARTS-HF trial, which showed finerenone's benefits in heart failure outcomes, shows no significant ...

The interaction between the gut microbiome and metabolites may mediate the effects of exposure to per- and polyfluoroalkyl ...

which may include eGFR slope, is used Presented five posters at the ASN Kidney Week, including one late-breaking clinical trial and four posters on rilparencel’s product characterization and MOA Ended ...

In a 24-week trial, semaglutide led to a 52% reduction in albuminuria and improved kidney health in individuals with chronic ...

近日，港股创新药企云顶新耀（HKEX 1952.HK）重磅产品——全球首个IgA肾病对因治疗药物耐赋康® (布地奈德肠溶胶囊)NefIgArd III期临床试验的全球开放标签扩展 (OLE)研究，在美国肾脏病协会肾脏周（ASN Kidney Week 2024）上公布积极数据。研究分析揭示，对于已完成NefIgArd ...

Although finerenone has kidney protective effects in patients with chronic kidney disease and type 2 diabetes, it does not appear to slow kidney function decline in patients with heart failure with ...